Clinical Trials

Pneumococcal Vaccine

Posted on 6/7/2019
This is a research study to test a vaccine that has not been approved for sale by the FDA.  The vaccine is being studied to protect against pneumococcal disease. The purpose of this study is to test the safety of the study vaccine to see how well the vaccine works when given at the same time as other recommended childhood vaccines. 

Your child would receive either the pneumococcal study vaccine or Prevar 13, which is already approved.  Your child will receive the vaccine at 2, 4, 6, 12 and 15 months of age.  In addition, your child will receive all the other normal vaccinations (RotaTeq, RECOMBIVAX HB, Pentacel, HIBERIX, M-M-R II, VARIVAX, VAQTA)

Your child may be able to join this study if your child is a healthy infant about 2 months old.

Your child will be in the study about 16-20 months and visit the study site about 6 times.

All study visits, procedures and study vaccinations will be provided at no cost to you or your insurance company.  In addition, you will be compensated for your time and travel if you decide to allow your child participate.  If you and your child complete the study, you will receive up to $510.00.
What Our Research Patients are Saying
"I was on edge when I first went to DCOL Research because of the sensitive nature of my diagnosis. Upon arrival to the research office I was treated very kindly and professionally as soon as I signed in. The Research Coordinator was friendly and compassionate and made me feel at ease. I was informed about the trial and they ensured that I had a clear understanding of the information. During all my visits I felt at ease and informed. The Research Coordinator is very professional as is the Lab Coordinator. It is always a smooth process and the staff is confident and friendly. The study doctor is also helpful and always asks if I have any problems or concerns, just like the staff."

~ Anonymous

Contact Form


  
DCOL of Longview